UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.

30/09/2023 30/09/2023

American psychiatrists' opinions about classic hallucinogens and their potential therapeutic applications: A 7-year follow-up survey

Our data reveal a striking positive shift in attitudes toward the therapeutic potential of hallucinogens among American psychiatrists since 2016, with a majority of responding psychiatrists planning to incorporate hallucinogen-assisted therapy into their practice if regulatory approval is granted.

15/09/2023 15/09/2023

“We don’t want to run before we walk”: the attitudes of Australian stakeholders towards using psychedelics for mental health conditions

Additional research and a clear presentation of this research are needed before the clinical use of psychedelics can be supported.

18/02/2023 18/02/2023

The prescription of psychedelic therapies in Australia and New Zealand: A brief survey of psychiatrists

we suggest there is scope to develop up-to-date education about psychedelics for psychiatrists.

20/08/2022 20/08/2022

Naturalistic psychedelic use: A world apart from clinical care

Among 1,435 participants, 72.5% never discussed psychedelic use with their primary care provider (PCP).

29/12/2021 29/12/2021

Most addiction specialists support legalized therapeutic psychedelics

The majority of US addiction specialists, including psychiatrists, believe psychedelics are promising for the treatment of substance use disorders.

09/12/2021 09/12/2021

The readiness of psychiatrists to implement psychedelic-assisted psychotherapy

NHS psychiatrists are positive about the potential for psychedelic-assisted therapy to advance psychiatric practise.

07/08/2021 07/08/2021

Cancer healthcare workers’ perceptions toward psychedelic-assisted therapy: A preliminary investigation

Cancer healthcare workers’ perceptions toward psychedelic-assisted therapy

04/07/2021 04/07/2021

YouGov results - Is the UK ready to reschedule psilocybin?

UK survey on attitudes to psilocybin